S&P 500   2,999.33 (+0.32%)
DOW   27,044.35 (+0.16%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
NFLX   296.00 (+3.40%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,999.33 (+0.32%)
DOW   27,044.35 (+0.16%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
NFLX   296.00 (+3.40%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

NeoGenomics News Headlines (NASDAQ:NEO)

$20.41
+0.20 (+0.99 %)
(As of 10/17/2019 02:30 PM ET)
Today's Range
$20.35
Now: $20.41
$20.55
50-Day Range
$18.95
MA: $21.59
$24.98
52-Week Range
$11.05
Now: $20.41
$26.89
Volume9,484 shs
Average Volume958,798 shs
Market Capitalization$2.12 billion
P/E Ratio157.08
Dividend YieldN/A
Beta0.92

Headlines

NeoGenomics (NASDAQ NEO) News Headlines

Source:
DateHeadline
NeoGenomics, Inc. (NASDAQ:NEO) Sees Significant Increase in Short InterestNeoGenomics, Inc. (NASDAQ:NEO) Sees Significant Increase in Short Interest
www.americanbankingnews.com - October 14 at 4:20 PM
Heres Why Genetic Testing Stocks Tumbled in September - The Motley FoolHere's Why Genetic Testing Stocks Tumbled in September - The Motley Fool
www.fool.com - October 5 at 10:28 PM
NeoGenomics Schedules its Third Quarter Earnings Release for October 29, 2019 - StreetInsider.comNeoGenomics Schedules its Third Quarter Earnings Release for October 29, 2019 - StreetInsider.com
www.streetinsider.com - October 3 at 9:38 PM
NeoGenomics Schedules its Third Quarter Earnings Release for October 29, 2019 - Yahoo FinanceNeoGenomics Schedules its Third Quarter Earnings Release for October 29, 2019 - Yahoo Finance
finance.yahoo.com - October 1 at 9:02 PM
NeoGenomics Schedules its Third Quarter Earnings Release for October 29, 2019NeoGenomics Schedules its Third Quarter Earnings Release for October 29, 2019
finance.yahoo.com - October 1 at 9:02 PM
$99.21 Million in Sales Expected for NeoGenomics, Inc. (NASDAQ:NEO) This Quarter$99.21 Million in Sales Expected for NeoGenomics, Inc. (NASDAQ:NEO) This Quarter
www.americanbankingnews.com - September 27 at 2:42 AM
NeoGenomics To Present At 2019 Cantor Global Healthcare Conference - StreetInsider.comNeoGenomics To Present At 2019 Cantor Global Healthcare Conference - StreetInsider.com
www.streetinsider.com - September 26 at 8:28 PM
NeoGenomics, Inc.: NeoGenomics To Present At 2019 Cantor Global Healthcare ConferenceNeoGenomics, Inc.: NeoGenomics To Present At 2019 Cantor Global Healthcare Conference
www.finanznachrichten.de - September 26 at 3:28 PM
NeoGenomics To Present At 2019 Cantor Global Healthcare Conference - Yahoo FinanceNeoGenomics To Present At 2019 Cantor Global Healthcare Conference - Yahoo Finance
finance.yahoo.com - September 25 at 7:25 PM
NeoGenomics To Present At 2019 Cantor Global Healthcare ConferenceNeoGenomics To Present At 2019 Cantor Global Healthcare Conference
finance.yahoo.com - September 25 at 7:25 PM
$0.06 Earnings Per Share Expected for NeoGenomics, Inc. (NASDAQ:NEO) This Quarter$0.06 Earnings Per Share Expected for NeoGenomics, Inc. (NASDAQ:NEO) This Quarter
www.americanbankingnews.com - September 25 at 10:43 AM
Introducing NeoGenomics (NASDAQ:NEO), The Stock That Zoomed 298% In The Last Five Years - Yahoo FinanceIntroducing NeoGenomics (NASDAQ:NEO), The Stock That Zoomed 298% In The Last Five Years - Yahoo Finance
finance.yahoo.com - September 17 at 10:30 AM
Introducing NeoGenomics (NASDAQ:NEO), The Stock That Zoomed 298% In The Last Five YearsIntroducing NeoGenomics (NASDAQ:NEO), The Stock That Zoomed 298% In The Last Five Years
finance.yahoo.com - September 17 at 10:30 AM
NeoGenomics Has Attractive Charts and Should Continue Its UptrendNeoGenomics Has Attractive Charts and Should Continue Its Uptrend
finance.yahoo.com - September 10 at 6:44 AM
Jim Cramer Gives His Opinion On NeoGenomics, Yeti And More - BenzingaJim Cramer Gives His Opinion On NeoGenomics, Yeti And More - Benzinga
www.benzinga.com - September 7 at 7:29 PM
NeoGenomics to Participate in Two Upcoming September Institutional Investor Conferences - Yahoo FinanceNeoGenomics to Participate in Two Upcoming September Institutional Investor Conferences - Yahoo Finance
finance.yahoo.com - September 3 at 7:23 PM
NeoGenomics to Participate in Two Upcoming September Institutional Investor ConferencesNeoGenomics to Participate in Two Upcoming September Institutional Investor Conferences
finance.yahoo.com - September 3 at 7:23 PM
We Think NeoGenomics (NASDAQ:NEO) Can Manage Its Debt With EaseWe Think NeoGenomics (NASDAQ:NEO) Can Manage Its Debt With Ease
finance.yahoo.com - August 12 at 11:56 AM
NeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial Guidance - Yahoo FinanceNeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial Guidance - Yahoo Finance
finance.yahoo.com - August 10 at 11:41 PM
NeoGenomics, Inc.: NeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial GuidanceNeoGenomics, Inc.: NeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial Guidance
www.finanznachrichten.de - August 10 at 6:40 PM
NeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial Guidance - StreetInsider.comNeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial Guidance - StreetInsider.com
www.streetinsider.com - August 9 at 12:32 AM
NeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial GuidanceNeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial Guidance
finance.yahoo.com - August 8 at 8:58 AM
Heres Why Genetic Testing Stocks Rose as Much as 25.4% in July - Yahoo FinanceHere's Why Genetic Testing Stocks Rose as Much as 25.4% in July - Yahoo Finance
finance.yahoo.com - August 5 at 8:09 PM
Form 8-K NEOGENOMICS INC For: Aug 02 - StreetInsider.comForm 8-K NEOGENOMICS INC For: Aug 02 - StreetInsider.com
www.streetinsider.com - August 3 at 1:47 AM
Genetic testers rally on insurance coverage for Myriads GeneSight - Seeking AlphaGenetic testers rally on insurance coverage for Myriad's GeneSight - Seeking Alpha
seekingalpha.com - August 1 at 8:14 PM
NEO Breaks OutNEO Breaks Out
finance.yahoo.com - August 1 at 8:14 PM
IBD Stock Of The Day With 93% Gain This Year Breaks Out AgainIBD Stock Of The Day With 93% Gain This Year Breaks Out Again
finance.yahoo.com - August 1 at 8:14 PM
Edited Transcript of NEO earnings conference call or presentation 30-Jul-19 12:30pm GMTEdited Transcript of NEO earnings conference call or presentation 30-Jul-19 12:30pm GMT
finance.yahoo.com - July 31 at 8:04 PM
Neogenomics (NEO) PT Raised to $27 at Needham & Company - StreetInsider.comNeogenomics (NEO) PT Raised to $27 at Needham & Company - StreetInsider.com
www.streetinsider.com - July 31 at 8:58 AM
NeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore - Yahoo FinanceNeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore - Yahoo Finance
finance.yahoo.com - July 31 at 8:58 AM
NeoGenomics Announces Grand Opening of New Pharma Services Laboratory in SingaporeNeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore
finance.yahoo.com - July 31 at 8:58 AM
NeoGenomics, Inc. (NEO) CEO Doug VanOort on Q2 2019 Results - Earnings Call Transcript - Seeking AlphaNeoGenomics, Inc. (NEO) CEO Doug VanOort on Q2 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - July 30 at 7:55 PM
NeoGenomics Q2 revenue up 50%; earnings down 66%; shares down 4% premarket - Seeking AlphaNeoGenomics Q2 revenue up 50%; earnings down 66%; shares down 4% premarket - Seeking Alpha
seekingalpha.com - July 30 at 7:55 PM
NeoGenomics (NEO) Meets Q2 Earnings Estimates - Yahoo FinanceNeoGenomics (NEO) Meets Q2 Earnings Estimates - Yahoo Finance
finance.yahoo.com - July 30 at 7:55 PM
NeoGenomics (NEO) Meets Q2 Earnings EstimatesNeoGenomics (NEO) Meets Q2 Earnings Estimates
finance.yahoo.com - July 30 at 7:55 PM
Neogenomics Inc (NEO) Q2 2019 Earnings Call TranscriptNeogenomics Inc (NEO) Q2 2019 Earnings Call Transcript
finance.yahoo.com - July 30 at 7:55 PM
NeoGenomics EPS beats by $0.01, beats on revenue - Seeking AlphaNeoGenomics EPS beats by $0.01, beats on revenue - Seeking Alpha
seekingalpha.com - July 30 at 10:05 AM
NeoGenomics Reports 50% Revenue Growth to Record $102 Million in the Second Quarter - StreetInsider.comNeoGenomics Reports 50% Revenue Growth to Record $102 Million in the Second Quarter - StreetInsider.com
www.streetinsider.com - July 30 at 10:05 AM
NeoGenomics Reports 50% Revenue Growth to Record $102 Million in the Second QuarterNeoGenomics Reports 50% Revenue Growth to Record $102 Million in the Second Quarter
finance.yahoo.com - July 30 at 10:05 AM
NeoGenomics (NEO) Earnings Expected to Grow: Should You Buy? - Yahoo FinanceNeoGenomics (NEO) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
finance.yahoo.com - July 24 at 12:34 PM
NeoGenomics (NEO) Earnings Expected to Grow: Should You Buy?NeoGenomics (NEO) Earnings Expected to Grow: Should You Buy?
finance.yahoo.com - July 24 at 12:34 PM
Outlook on the Global Novel Immuno-Oncology Biomarker Testing to 2030 - Increasing Focus on Precision Medicine & Rise in Number of Biomarker-based Clinical Trials Presents Opportunities - GlobeNewswireOutlook on the Global Novel Immuno-Oncology Biomarker Testing to 2030 - Increasing Focus on Precision Medicine & Rise in Number of Biomarker-based Clinical Trials Presents Opportunities - GlobeNewswire
globenewswire.com - July 22 at 6:59 PM
Novel Immuno-oncology Biomarker Testing: World Markets (2019-2030) with Profiles on Foundation Medicine, Lal PathLabs, NeoGenomics Labs, Novogene, Q2 Solutions, Personal Genome Diagnostics, and More - PRNewswireNovel Immuno-oncology Biomarker Testing: World Markets (2019-2030) with Profiles on Foundation Medicine, Lal PathLabs, NeoGenomics Labs, Novogene, Q2 Solutions, Personal Genome Diagnostics, and More - PRNewswire
www.prnewswire.com - July 22 at 6:59 PM
NeoGenomics Reaches Analyst Target Price - NasdaqNeoGenomics Reaches Analyst Target Price - Nasdaq
www.nasdaq.com - July 18 at 9:24 AM
Heres Why NeoGenomics Stock Rose 74% in the First Half of the Year - NasdaqHere's Why NeoGenomics Stock Rose 74% in the First Half of the Year - Nasdaq
www.nasdaq.com - July 12 at 6:25 PM
NeoGenomics, Inc. (NASDAQ:NEO): Financial Strength AnalysisNeoGenomics, Inc. (NASDAQ:NEO): Financial Strength Analysis
finance.yahoo.com - July 11 at 5:54 PM
NeoGenomics to Build State-of-the-Art Oncology Laboratory and Global Headquarters in Fort Myers, Florida - Yahoo FinanceNeoGenomics to Build State-of-the-Art Oncology Laboratory and Global Headquarters in Fort Myers, Florida - Yahoo Finance
finance.yahoo.com - July 9 at 8:53 AM
NeoGenomics to Build State-of-the-Art Oncology Laboratory and Global Headquarters in Fort Myers, FloridaNeoGenomics to Build State-of-the-Art Oncology Laboratory and Global Headquarters in Fort Myers, Florida
finance.yahoo.com - July 9 at 8:53 AM
Cancer/Tumor Profiling: Worldwide Markets Through 2019-2024 - The Increasing Use of Biomarkers in Cancer Profiling Drives the Market - Yahoo FinanceCancer/Tumor Profiling: Worldwide Markets Through 2019-2024 - The Increasing Use of Biomarkers in Cancer Profiling Drives the Market - Yahoo Finance
finance.yahoo.com - July 4 at 6:21 PM
Global Cancer/Tumor Profiling Market to 2024 (Immunoassay, NGS, PCR, In Situ Hybridization): NGS Segment Expected to Grow at the Highest Rate During the Forecast Period - Yahoo FinanceGlobal Cancer/Tumor Profiling Market to 2024 (Immunoassay, NGS, PCR, In Situ Hybridization): NGS Segment Expected to Grow at the Highest Rate During the Forecast Period - Yahoo Finance
finance.yahoo.com - July 4 at 8:56 AM
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Featured Article: Bid-Ask Spread

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel